Regorafenib
AG0315OG/CTC0140
Phase 3 small_molecule active
Quick answer
Regorafenib for Gastro-Oesophageal Cancer is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Gastro-Oesophageal Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active